NextDocs
Total Raised
$32.3MInvestors Count
4Deal Terms
2Funding, Valuation & Revenue
5 Fundings
NextDocs has raised $32.3M over 5 rounds.
NextDocs's latest funding round was a Acquired for on June 1, 2015.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
6/1/2015 | Acquired | 1 | ||||
10/29/2013 | Line of Credit | |||||
9/10/2013 | Series B | |||||
8/26/2013 | Debt | |||||
8/22/2011 | Series A |
Date | 6/1/2015 | 10/29/2013 | 9/10/2013 | 8/26/2013 | 8/22/2011 |
|---|---|---|---|---|---|
Round | Acquired | Line of Credit | Series B | Debt | Series A |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
NextDocs Deal Terms
2 Deal Terms
NextDocs's deal structure is available for 2 funding rounds, including their Series B from September 10, 2013.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
NextDocs Investors
4 Investors
NextDocs has 4 investors. Aurea Software invested in NextDocs's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
6/1/2015 | 6/1/2015 | 1 Acquired | Corporation | Texas | ||
Investment Bank | California | |||||
Venture Capital | Massachusetts | |||||
Debt & Specialty Finance | Massachusetts |
First funding | 6/1/2015 | |||
|---|---|---|---|---|
Last Funding | 6/1/2015 | |||
Investor | ||||
Rounds | 1 Acquired | |||
Board Seats | ||||
Type | Corporation | Investment Bank | Venture Capital | Debt & Specialty Finance |
Location | Texas | California | Massachusetts | Massachusetts |
Compare NextDocs to Competitors
Endpoint Clinical provides randomization and trial supply management (RTSM) solutions for the life sciences industry. The company's offerings consist of RTSM solutions that support patient randomization, site management, and drug supply management for clinical trials. Endpoint Clinical serves the life sciences sector with tools and services for clinical trial operations. It was founded in 2009 and is based in Raleigh, North Carolina.
Medrio provides clinical trial solutions within the healthcare sector, with a focus on clinical research processes. The company offers eClinical solutions such as electronic data capture, clinical data management, electronic patient-reported assessments, randomization, trial supply management, and electronic consent. Medrio's services are applicable to sectors including MedTech, Pharma, Biotech, CRO, Consultants, and Animal Health. It was founded in 2005 and is based in San Francisco, California.
Clinical Ink is a global life science technology company that provides clinical trial solutions. The company offers an eSource platform that integrates Direct Data Capture and electronic Clinical Outcome Assessments. Clinical Ink's services are focused on decentralized clinical trials and various therapeutic areas, including neurology, infectious disease, immunology, and oncology. It is based in Winston-Salem, North Carolina.
goBalto develops cloud-based solutions that simplify how clinical trials are conducted in the pharmaceutical, biotechnology, and medical device industries. The company's flagship product, Tracker, is a purpose-built software-as-a-service clinical research tool. It enables clinical trial sponsors and research organizations to track and collaborate on operational data in a transparent, regulatory-compliant, and user-friendly way.
Comprehend Systems offers cloud-based clinical data insights tools that improve the way clinical researchers access, understand, explore and analyze data. Designed specifically for life sciences, Comprehend Clinical enables data managers, monitors and clinical operations executives to identify broad operational and clinical trends across trials and also easily drill down and report on a wide range of factors, including safety issues, regulatory requirements and opportunities for critical time and cost savings.
Loading...